These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28462890)

  • 1. Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting 2016.
    Terpos E;
    Clin Lymphoma Myeloma Leuk; 2017 Jun; 17(6):329-339. PubMed ID: 28462890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting, 2017.
    Terpos E;
    Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):321-334. PubMed ID: 29576386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020.
    Devarakonda S; Cottini F; Bumma N; Khan A; Sharma N; Chaudhry M; Benson D; Rosko A; Efebera Y
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33187184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting 2018.
    Terpos E; Ntanasis-Stathopoulos I;
    Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e324-e336. PubMed ID: 31076371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Updates Regarding Multiple Myeloma From the 2019 American Society of Hematology Annual Meeting.
    Terpos E; Ntanasis-Stathopoulos I;
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):499-508. PubMed ID: 32376237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights of Multiple Myeloma at the Annual Meeting of American Society of Hematology, 2016.
    Tandon N; Kumar SK
    Indian J Hematol Blood Transfus; 2017 Jun; 33(2):153-158. PubMed ID: 28596644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Hematology Annual Meeting 2014: highlights in multiple myeloma.
    Glavey SV; Ghobrial IM
    Expert Rev Hematol; 2015 Jun; 8(3):273-5. PubMed ID: 25804827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.
    Merz M; Raab MS; Goldschmidt H; Hillengass J
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2521-2526. PubMed ID: 28653099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020.
    Du J; Zhuang J
    Chronic Dis Transl Med; 2021 Dec; 7(4):220-226. PubMed ID: 34786541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy.
    Voorhees PM; Usmani SZ
    Clin Adv Hematol Oncol; 2016 Sep; 14(9):719-28. PubMed ID: 27673290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.
    Malard F; Harousseau JL; Mohty M
    Cancer Treat Rev; 2017 Jan; 52():41-47. PubMed ID: 27888768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease.
    Ashjian E; Redic K
    J Oncol Pharm Pract; 2016 Apr; 22(2):289-302. PubMed ID: 25694345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment algorithms for multiple myeloma in Japan].
    Ozaki S
    Rinsho Ketsueki; 2017; 58(8):1014-1023. PubMed ID: 28883264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How is patient care for multiple myeloma advancing?
    Genadieva Stavric S; Bonello F; Bringhen S; Boccadoro M; Larocca A
    Expert Rev Hematol; 2017 Jun; 10(6):551-561. PubMed ID: 28504554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which therapies will move to the front line for multiple myeloma?
    Cejalvo MJ; de la Rubia J
    Expert Rev Hematol; 2017 May; 10(5):383-392. PubMed ID: 28388244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidence.
    Musto P; La Rocca F
    Expert Rev Hematol; 2020 May; 13(5):501-517. PubMed ID: 32290723
    [No Abstract]   [Full Text] [Related]  

  • 17. Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials.
    Boudreault JS; Touzeau C; Moreau P
    Expert Rev Hematol; 2017 Mar; 10(3):207-215. PubMed ID: 28110581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic approach for relapsed/refractory multiple myeloma: the logic and practice].
    Kuroda J
    Rinsho Ketsueki; 2017; 58(10):2058-2066. PubMed ID: 28978849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selinexor: Targeting a novel pathway in multiple myeloma.
    Mo CC; Yee AJ; Midha S; Hartley-Brown MA; Nadeem O; O'Donnell EK; Bianchi G; Sperling AS; Laubach JP; Richardson PG
    EJHaem; 2023 Aug; 4(3):792-810. PubMed ID: 37601856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapeutic strategies for multiple myeloma.
    Torimoto Y; Shindo M; Ikuta K; Kohgo Y
    Int J Clin Oncol; 2015 Jun; 20(3):423-30. PubMed ID: 25855312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.